Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02196818 · ClinicalTrials.gov registry record
A Multi-centre, Prospective Surveillance to Assess Mid-term Performance of the Mpact Cup
A clinical trial, sponsored by Medacta International.
- Terminated
- Registry status
- 200
- Enrollment target
NCT02196818: Clinical Trial study, sponsored by Medacta International.
NCT02196818 is a clinical trial that was terminated before completion, run by Medacta International. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02196818 was terminated before completion, sponsored by Medacta International.
- TERMINATED
- Registry status
- 200 participants
- Enrollment target
Study Summary
This is a multi-centre, prospective post marketing surveillance study to assess mid-term performance of the Mpact cup in subjects requiring primary total hip arthroplasty.
Interventions
- DEVICE Mpact Acetabular Shell
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2013-03 |
| Est. Completion | 2022-04 |
Why NCT02196818 stopped before completion
NCT02196818 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Mpact Acetabular Shell is the first listed.
NCT02196818 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02196818 about?
NCT02196818 is a clinical study titled "A Multi-centre, Prospective Surveillance to Assess Mid-term Performance of the Mpact Cup". This is a multi-centre, prospective post marketing surveillance study to assess mid-term performance of the Mpact cup in subjects requiring primary total hip arthroplasty.
What is the current status of trial NCT02196818?
This trial is currently terminated. The enrollment target is 200 participants. The study started on 2013-03. Estimated completion is 2022-04.
What interventions are being tested in trial NCT02196818?
The interventions under investigation include: Mpact Acetabular Shell (DEVICE).
Who is sponsoring clinical trial NCT02196818?
This trial is sponsored by Medacta International, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia